• Explore /
  • Poster
  • / Efficacy of tyrosine kinase inhibitors (TKI) after combination ipilimumab plus nivolumab (I/N) in metastatic clear cell renal cell carcinoma (ccmRCC) patients: Results from the Canadian Kidney Cancer Information System (CKCis).

Efficacy of tyrosine kinase inhibitors (TKI) after combination ipilimumab plus nivolumab (I/N) in metastatic clear cell renal cell carcinoma (ccmRCC) patients: Results from the Canadian Kidney Cancer Information System (CKCis).

Abstract Poster

Authors

null

Austin Kalirai

University of Queensland, Brisbane, QLD, Australia

Austin Kalirai , Isaiah Joy , Sunita Ghosh , Christian K. Kollmannsberger , Aaron Richard Hansen , Myuran Thana , Jeffrey Graham , Daniel Yick Chin Heng , Vincent Castonguay , Georg A. Bjarnason , Rodney H. Breau , Anil Kapoor , Frederic Pouliot , Lori Wood , Naveen S. Basappa

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral, and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer

Sub Track

Therapeutics

Citation

J Clin Oncol 40, 2022 (suppl 6; abstr 346)

DOI

10.1200/JCO.2022.40.6_suppl.346

Abstract #

346

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Jeffrey Graham

First Author: Sam Wong

Poster

2019 Genitourinary Cancers Symposium

Eficacy and safety of first-line TKI in elderly with metastatic renal cancer.

Eficacy and safety of first-line TKI in elderly with metastatic renal cancer.

First Author: Luciana de Moura Leite

First Author: Amishi Yogesh Shah